NO993172D0 - Sulfonamid-forbindelser med 5-HT-reseptor-aktivitet - Google Patents
Sulfonamid-forbindelser med 5-HT-reseptor-aktivitetInfo
- Publication number
- NO993172D0 NO993172D0 NO993172A NO993172A NO993172D0 NO 993172 D0 NO993172 D0 NO 993172D0 NO 993172 A NO993172 A NO 993172A NO 993172 A NO993172 A NO 993172A NO 993172 D0 NO993172 D0 NO 993172D0
- Authority
- NO
- Norway
- Prior art keywords
- receptor activity
- sulfonamide compounds
- sulfonamide
- compounds
- receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Light Receiving Elements (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9627006.1A GB9627006D0 (en) | 1996-12-27 | 1996-12-27 | Therapeutic agents |
| PCT/EP1997/007034 WO1998029411A1 (en) | 1996-12-27 | 1997-12-15 | Sulfonamide compounds having 5-ht receptor activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993172L NO993172L (no) | 1999-06-25 |
| NO993172D0 true NO993172D0 (no) | 1999-06-25 |
Family
ID=10805084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993172A NO993172D0 (no) | 1996-12-27 | 1999-06-25 | Sulfonamid-forbindelser med 5-HT-reseptor-aktivitet |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6136825A (no) |
| EP (1) | EP0948498A1 (no) |
| JP (1) | JP2001508419A (no) |
| KR (1) | KR20000062356A (no) |
| CN (1) | CN1247537A (no) |
| AU (1) | AU747545B2 (no) |
| BG (1) | BG103557A (no) |
| BR (1) | BR9714237A (no) |
| CA (1) | CA2275668A1 (no) |
| GB (1) | GB9627006D0 (no) |
| HU (1) | HUP0000489A3 (no) |
| IL (1) | IL130361A0 (no) |
| NO (1) | NO993172D0 (no) |
| NZ (1) | NZ336328A (no) |
| PL (1) | PL334254A1 (no) |
| SK (1) | SK82399A3 (no) |
| TR (1) | TR199901478T2 (no) |
| WO (1) | WO1998029411A1 (no) |
| ZA (1) | ZA9711551B (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1006794B1 (en) | 1997-03-12 | 2007-11-28 | Robert W. Esmond | A method for treating or preventing alzheimer's disease |
| GB9915617D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
| US6399617B1 (en) | 2000-07-21 | 2002-06-04 | Biovitrum Ab | Use |
| SE0002739D0 (sv) * | 2000-07-21 | 2000-07-21 | Pharmacia & Upjohn Ab | New use |
| WO2005080394A1 (en) * | 2004-02-24 | 2005-09-01 | Bioaxone Therapeutique Inc. | 4-substituted piperidine derivatives |
| US20080299674A1 (en) * | 2004-07-14 | 2008-12-04 | Yoshikazu Kitano | Novel Isonitrile Compound, Its Method Of Manufacture, A Marine Fouling Organism Larva Fluorescent, And A Method Of Detecting This Marine Fouling Organism Larva Using Said Marker |
| SI1831159T1 (sl) * | 2004-12-21 | 2010-04-30 | Hoffmann La Roche | Derivati tetralina in indana ter njune uporabe |
| PL395470A1 (pl) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Sulfonamidowe pochodne amin alicyklicznych do leczenia chorób osrodkowego ukladu nerwowego |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300523A (en) * | 1988-07-28 | 1994-04-05 | Bayer Aktiengesellschaft | Substituted aminomethyltetralins and their heterocyclic analogues |
| DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
| FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
| FR2701479B1 (fr) * | 1993-02-11 | 1995-05-12 | Pf Medicament | Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique. |
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
-
1996
- 1996-12-27 GB GBGB9627006.1A patent/GB9627006D0/en active Pending
-
1997
- 1997-12-15 BR BR9714237-9A patent/BR9714237A/pt not_active IP Right Cessation
- 1997-12-15 CA CA002275668A patent/CA2275668A1/en not_active Abandoned
- 1997-12-15 HU HU0000489A patent/HUP0000489A3/hu unknown
- 1997-12-15 JP JP52957498A patent/JP2001508419A/ja active Pending
- 1997-12-15 EP EP97953819A patent/EP0948498A1/en not_active Withdrawn
- 1997-12-15 TR TR1999/01478T patent/TR199901478T2/xx unknown
- 1997-12-15 KR KR1019997005840A patent/KR20000062356A/ko not_active Application Discontinuation
- 1997-12-15 NZ NZ336328A patent/NZ336328A/xx unknown
- 1997-12-15 CN CN97181916A patent/CN1247537A/zh active Pending
- 1997-12-15 IL IL13036197A patent/IL130361A0/xx unknown
- 1997-12-15 AU AU57580/98A patent/AU747545B2/en not_active Ceased
- 1997-12-15 WO PCT/EP1997/007034 patent/WO1998029411A1/en not_active Application Discontinuation
- 1997-12-15 US US09/331,066 patent/US6136825A/en not_active Expired - Lifetime
- 1997-12-15 PL PL97334254A patent/PL334254A1/xx unknown
- 1997-12-15 SK SK823-99A patent/SK82399A3/sk unknown
- 1997-12-23 ZA ZA9711551A patent/ZA9711551B/xx unknown
-
1999
- 1999-06-25 NO NO993172A patent/NO993172D0/no not_active Application Discontinuation
- 1999-07-06 BG BG103557A patent/BG103557A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO993172L (no) | 1999-06-25 |
| GB9627006D0 (en) | 1997-02-12 |
| NZ336328A (en) | 2000-09-29 |
| ZA9711551B (en) | 1999-06-23 |
| WO1998029411A1 (en) | 1998-07-09 |
| BG103557A (en) | 2000-06-30 |
| PL334254A1 (en) | 2000-02-14 |
| KR20000062356A (ko) | 2000-10-25 |
| JP2001508419A (ja) | 2001-06-26 |
| CN1247537A (zh) | 2000-03-15 |
| AU747545B2 (en) | 2002-05-16 |
| AU5758098A (en) | 1998-07-31 |
| US6136825A (en) | 2000-10-24 |
| CA2275668A1 (en) | 1998-07-09 |
| EP0948498A1 (en) | 1999-10-13 |
| SK82399A3 (en) | 2000-05-16 |
| HUP0000489A3 (en) | 2001-06-28 |
| IL130361A0 (en) | 2000-06-01 |
| TR199901478T2 (xx) | 1999-09-21 |
| HUP0000489A2 (hu) | 2000-12-28 |
| BR9714237A (pt) | 2000-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| IL174074A0 (en) | Arylpiperazines having activity at the serotonin 1a receptor | |
| FI973816A0 (fi) | Polypropen med hoeg smaeltstyrka | |
| BR9508178A (pt) | Antagonistas de receptor de vitronectina | |
| DE69812096D1 (de) | Neuropeptid y rezeptorantagonisten | |
| IS5860A (is) | 4,4-bíarýlpíperidín afleiður með ópíóíð viðtaka virkni | |
| NO985225D0 (no) | Indolderivater nyttige som endotelinreseptorantagonister | |
| DK0856001T3 (da) | Pyrimidinderivater som 5-HT2C-receptor-antagonister | |
| PT1131291E (pt) | Antagonistas iii do receptor 4-aroil-piperidin-ccr-3 | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| DK0906294T3 (da) | Benzoxazinon-dopamin D4-receptor-antagonister | |
| DE69506826D1 (de) | 5-HT4 Rezeptoragonisten | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| NO994106D0 (no) | Oksazolidiner som 5-HT2A-antagonister | |
| DZ2322A1 (fr) | Antagonistes de récepteurs de vitronectine. | |
| NO993172D0 (no) | Sulfonamid-forbindelser med 5-HT-reseptor-aktivitet | |
| TR199501389A2 (tr) | Adesyon reseptörü antagonistleri (karsitlari). | |
| NO985970L (no) | Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister | |
| FI962419A0 (fi) | Ringoskillator med hoeg hastighet | |
| DE69821325D1 (de) | Baustütze | |
| NO985972L (no) | Indolinderivater anvendelige som 5-HT-2C reseptorantagonister | |
| NO972771D0 (no) | Ny reseptor | |
| FI973594A0 (fi) | Istuinrakenne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |